Md. Rizwanullah

2.9k total citations
57 papers, 2.2k citations indexed

About

Md. Rizwanullah is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Md. Rizwanullah has authored 57 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmaceutical Science, 22 papers in Biomaterials and 17 papers in Molecular Biology. Recurrent topics in Md. Rizwanullah's work include Nanoparticle-Based Drug Delivery (22 papers), Advanced Drug Delivery Systems (17 papers) and Advancements in Transdermal Drug Delivery (13 papers). Md. Rizwanullah is often cited by papers focused on Nanoparticle-Based Drug Delivery (22 papers), Advanced Drug Delivery Systems (17 papers) and Advancements in Transdermal Drug Delivery (13 papers). Md. Rizwanullah collaborates with scholars based in India, Saudi Arabia and France. Md. Rizwanullah's co-authors include Saima Amin, Javed Ahmad, Showkat R. Mir, Syed Sarim Imam, Sultan Alshehri, Mohammad Zaki Ahmad, Mohammad Ahmed Khan, Keerti Jain, Vineet Jain and Sohail Akhter and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and International Journal of Biological Macromolecules.

In The Last Decade

Md. Rizwanullah

56 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Md. Rizwanullah India 28 742 741 714 461 193 57 2.2k
Lejiao Jia China 24 740 1.0× 714 1.0× 812 1.1× 309 0.7× 158 0.8× 39 1.9k
Varun Kushwah India 34 895 1.2× 1.1k 1.5× 876 1.2× 434 0.9× 242 1.3× 88 2.8k
Jaber Emami Iran 29 713 1.0× 922 1.2× 643 0.9× 341 0.7× 180 0.9× 80 2.5k
Hibah M. Aldawsari Saudi Arabia 28 864 1.2× 633 0.9× 404 0.6× 304 0.7× 242 1.3× 84 2.4k
Huixia Lv China 30 1.1k 1.5× 694 0.9× 709 1.0× 405 0.9× 221 1.1× 77 2.7k
Saima Amin India 26 617 0.8× 958 1.3× 532 0.7× 295 0.6× 162 0.8× 103 2.4k
Omer Salman Qureshi Pakistan 17 668 0.9× 734 1.0× 711 1.0× 505 1.1× 136 0.7× 25 2.1k
Khalid M. El‐Say Saudi Arabia 25 557 0.8× 987 1.3× 628 0.9× 494 1.1× 87 0.5× 77 2.3k
Maged W. Helmy Egypt 33 970 1.3× 334 0.5× 792 1.1× 464 1.0× 263 1.4× 104 2.8k
Yosra S.R. Elnaggar Egypt 32 740 1.0× 1.2k 1.6× 545 0.8× 298 0.6× 238 1.2× 60 3.0k

Countries citing papers authored by Md. Rizwanullah

Since Specialization
Citations

This map shows the geographic impact of Md. Rizwanullah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md. Rizwanullah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md. Rizwanullah more than expected).

Fields of papers citing papers by Md. Rizwanullah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Md. Rizwanullah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md. Rizwanullah. The network helps show where Md. Rizwanullah may publish in the future.

Co-authorship network of co-authors of Md. Rizwanullah

This figure shows the co-authorship network connecting the top 25 collaborators of Md. Rizwanullah. A scholar is included among the top collaborators of Md. Rizwanullah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Md. Rizwanullah. Md. Rizwanullah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizwanullah, Md., et al.. (2025). Recent advancement in polymeric nanoparticles for oral chemotherapy: Transforming cancer treatment. Bioimpacts. 15. 31117–31117.
2.
Fareed, Mohammad, et al.. (2025). Exploring the therapeutic potential of ligand-decorated nanostructured lipid carriers for targeted solid tumor therapy. International Journal of Pharmaceutics. 678. 125687–125687. 1 indexed citations
3.
Fareed, Mohammad, et al.. (2024). Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects. Beilstein Journal of Nanotechnology. 15. 1473–1497. 9 indexed citations
4.
Rizwanullah, Md., et al.. (2023). Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis. OpenNano. 10. 100123–100123. 24 indexed citations
5.
Afzal, Obaid, Md. Rizwanullah, Abdulmalik Saleh Alfawaz Altamimi, et al.. (2023). Harnessing natural polysaccharides-based nanoparticles for oral delivery of phytochemicals: Knocking down the barriers. Journal of Drug Delivery Science and Technology. 82. 104368–104368. 12 indexed citations
8.
Alhakamy, Nabil A., Shadab Md, Mohammad Zaki Ahmad, et al.. (2022). Nanogels as Potential Delivery Vehicles in Improving the Therapeutic Efficacy of Phytopharmaceuticals. Polymers. 14(19). 4141–4141. 17 indexed citations
9.
Ahmad, Javed, Md. Rizwanullah, Hassan A. Albarqi, et al.. (2022). Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications. Critical Reviews in Therapeutic Drug Carrier Systems. 39(6). 1–44. 19 indexed citations
10.
Rizwanullah, Md., et al.. (2022). Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization, in vitro and in vivo evaluation. Biomedical Materials. 17(6). 65009–65009. 23 indexed citations
11.
Rizwanullah, Md., Mohammad Zaki Ahmad, Mohammed M. Ghoneim, et al.. (2021). Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges. Pharmaceutics. 13(12). 2039–2039. 31 indexed citations
12.
Ahmad, Mohammad Zaki, Md. Rizwanullah, Javed Ahmad, et al.. (2021). Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy. International Journal of Polymeric Materials. 71(8). 602–623. 87 indexed citations
13.
Alshehri, Sultan, Syed Sarim Imam, Md. Rizwanullah, et al.. (2020). Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges. Pharmaceutics. 13(1). 24–24. 64 indexed citations
14.
Akhter, Md Habban, Md. Rizwanullah, Javed Ahmad, et al.. (2020). Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme. Drug Research. 71(3). 122–137. 25 indexed citations
15.
Khan, Mohammad Ahmed, Vineet Jain, Md. Rizwanullah, Javed Ahmad, & Keerti Jain. (2019). PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges. Drug Discovery Today. 24(11). 2181–2191. 190 indexed citations
16.
Rizwanullah, Md., et al.. (2017). Phytochemical based nanomedicines against cancer: current status and future prospects. Journal of drug targeting. 26(9). 731–752. 76 indexed citations
17.
Ahmad, Javed, Saima Amin, Md. Rizwanullah, et al.. (2017). Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides. Current Pharmaceutical Design. 23(11). 1575–1588. 68 indexed citations
18.
Rizwanullah, Md., Saima Amin, & Javed Ahmad. (2016). Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. Journal of drug targeting. 25(1). 58–74. 79 indexed citations
19.
Ahmad, Javed, Md. Rizwanullah, Mohammad Zaki Ahmad, et al.. (2015). Nanotechnology-based inhalation treatments for lung cancer: state of the art. SHILAP Revista de lepidopterología. 8. 55–55. 130 indexed citations
20.
Barkat, Md. Abul, et al.. (2014). Phytoconstituents as potential anti-HIV agents: A Systematic review. Scholar Science Journals - International Journal of Biomedical Research. 5(5). 299–313. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026